Child leukemia combo trial pulled before enrolling any patients
NCT ID NCT07052994
First seen Mar 08, 2026 · Last updated Jun 10, 2026 · Updated 15 times
Summary
This study was designed to find a safe dose of revumenib when given with standard chemotherapy drugs to children and young adults with acute leukemia. It was planned for two phases: first to test safety, then to see if the combination helps control the disease. However, the trial was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC ACUTE LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.